98 related articles for article (PubMed ID: 9241438)
1. Potassium channel opener reduces extracellular glutamate concentration in rat focal cerebral ischemia.
Fujita H; Takizawa S; Nanri K; Matsushima K; Ogawa S; Shinohara Y
Brain Res Bull; 1997; 43(4):365-8. PubMed ID: 9241438
[TBL] [Abstract][Full Text] [Related]
2. A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume in focal cerebral ischemia.
Takizawa S; Matsushima K; Fujita H; Nanri K; Ogawa S; Shinohara Y
J Cereb Blood Flow Metab; 1995 Jul; 15(4):611-8. PubMed ID: 7790409
[TBL] [Abstract][Full Text] [Related]
3. An ATP-sensitive potassium channel activator reduces infarct volume in focal cerebral ischemia in rats.
Takaba H; Nagao T; Yao H; Kitazono T; Ibayashi S; Fujishima M
Am J Physiol; 1997 Aug; 273(2 Pt 2):R583-6. PubMed ID: 9277542
[TBL] [Abstract][Full Text] [Related]
4. Altered cerebrovascular response to a potassium channel opener in hypertensive rats.
Takaba H; Nagao T; Ibayashi S; Kitazono T; Fujii K; Fujishima M
Hypertension; 1996 Jul; 28(1):143-6. PubMed ID: 8675255
[TBL] [Abstract][Full Text] [Related]
5. The mitochondrial K(ATP) channel opener BMS-191095 reduces neuronal damage after transient focal cerebral ischemia in rats.
Mayanagi K; Gáspár T; Katakam PV; Kis B; Busija DW
J Cereb Blood Flow Metab; 2007 Feb; 27(2):348-55. PubMed ID: 16736040
[TBL] [Abstract][Full Text] [Related]
6. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
Yao Z; Gross GJ
Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
[TBL] [Abstract][Full Text] [Related]
7. The antihypertensive and cardioprotective effects of (-)-MJ-451, an ATP-sensitive K(+) channel opener.
Lee YM; Yen MH; Peng YY; Sheu JR; Chen YC; Chang MJ; Cheng CY
Eur J Pharmacol; 2000 May; 397(1):151-60. PubMed ID: 10844109
[TBL] [Abstract][Full Text] [Related]
8. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbral region following middle cerebral artery occlusion in the rat: correlation with histopathology.
Takagi K; Ginsberg MD; Globus MY; Dietrich WD; Martinez E; Kraydieh S; Busto R
J Cereb Blood Flow Metab; 1993 Jul; 13(4):575-85. PubMed ID: 8100237
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the effects of a sodium channel blocker and an NMDA antagonist upon extracellular glutamate in rat focal cerebral ischemia.
Chen J; Graham SH; Simon RP
Brain Res; 1995 Nov; 699(1):121-4. PubMed ID: 8616600
[TBL] [Abstract][Full Text] [Related]
10. Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents.
Sargent CA; Smith MA; Dzwonczyk S; Sleph PG; Grover GJ
J Pharmacol Exp Ther; 1991 Oct; 259(1):97-103. PubMed ID: 1920138
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim.
Gross GJ; Mei DA; Sleph PG; Grover GJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):533-40. PubMed ID: 9023261
[TBL] [Abstract][Full Text] [Related]
12. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
Mizumura T; Nithipatikom K; Gross GJ
Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
[TBL] [Abstract][Full Text] [Related]
13. Isradipine, a calcium channel blocker, attenuates the ischemia-induced release of dopamine but not glutamate in rats.
Nakane H; Ooboshi H; Ibayashi S; Yao H; Sadoshima S; Fujishima M
Neurosci Lett; 1995 Mar; 188(3):151-4. PubMed ID: 7609897
[TBL] [Abstract][Full Text] [Related]
14. Relationship between extracellular glutamate concentration and voltage-sensitive calcium channel function in focal cerebral ischemia in the rat.
Osuga H; Hakim AM
J Cereb Blood Flow Metab; 1996 Jul; 16(4):629-36. PubMed ID: 8964802
[TBL] [Abstract][Full Text] [Related]
15. omega-agatoxin IVA-sensitive Ca(2+) channel blocker, alpha-eudesmol, protects against brain injury after focal ischemia in rats.
Asakura K; Matsuo Y; Oshima T; Kihara T; Minagawa K; Araki Y; Kagawa K; Kanemasa T; Ninomiya M
Eur J Pharmacol; 2000 Apr; 394(1):57-65. PubMed ID: 10771035
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport.
Hurtado O; Moro MA; Cárdenas A; Sánchez V; Fernández-Tomé P; Leza JC; Lorenzo P; Secades JJ; Lozano R; Dávalos A; Castillo J; Lizasoain I
Neurobiol Dis; 2005 Mar; 18(2):336-45. PubMed ID: 15686962
[TBL] [Abstract][Full Text] [Related]
17. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Tosaki A; Hellegouarch A
J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
[TBL] [Abstract][Full Text] [Related]
18. Effect of the potassium channel opener EMD 56431 on globally ischemic rat hearts.
Sargent CA; Dzwonczyk S; Grover GJ
Pharmacology; 1992; 45(5):260-8. PubMed ID: 1465473
[TBL] [Abstract][Full Text] [Related]
19. Real-time measurement of glutamate release from the ischemic penumbra of the rat cerebral cortex using a focal middle cerebral artery occlusion model.
Guyot LL; Diaz FG; O'Regan MH; McLeod S; Park H; Phillis JW
Neurosci Lett; 2001 Feb; 299(1-2):37-40. PubMed ID: 11166932
[TBL] [Abstract][Full Text] [Related]
20. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
Auchampach JA; Gross GJ
Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
